Literature DB >> 20981692

Child-related determinants of health-related quality of life in children with brain tumours 1 year after diagnosis.

Anthony Penn1, Robert I Shortman, Stephen P Lowis, Michael C G Stevens, Linda P Hunt, Renee J McCarter, Andrew L Curran, Peta M Sharples.   

Abstract

OBJECTIVES: Infratentorial tumour site and health-related quality of life (HRQL) 1 month after diagnosis have been shown to predict HRQL 1 year after diagnosis in children with brain tumours. This study aimed to identify additional early child-related determinants of parent- and child-report HRQL.
METHODS: Longitudinal prospective study. Semi-structured interviews took place approximately 1 and 12 months after diagnosis. HRQL was measured using the self- and parent-report Pediatric Quality of Life Scales (PedsQL 4.0) Total Scale Score and Health Utilities Index Mark 3 (HUI3) multi-attribute utility function. Child variables included performance and verbal IQ, general memory, selective attention executive function, behaviour problems, adaptive behaviour, symptoms of depression and anxiety and event related anxiety. Univariate analyses were used to identify potential early predictors of HRQL. Regression analysis was then used to identify the most important determinants of HRQL at 1 year.
RESULTS: Thirty-five patients completed the 12-month interviews. Multivariate analysis showed infratentorial tumour site remained an important determinant of HRQL 1 year after diagnosis. Infratentorial tumour site and selective attention at 1 month generally best predicted poor self- and parent-report HRQL at 12 months. Adaptive behaviour and performance IQ may be important.
CONCLUSION: Selective attention and infratentorial tumour site are most important in predicting both parent- and self-report HRQL at 1 year after diagnosis. Larger prospective studies are needed to confirm these findings. Cognitive remediation or/and pharmacological intervention, particularly aimed at children with infratentorial tumours may improve attention and subsequently HRQL and both merit further investigation.

Entities:  

Mesh:

Year:  2010        PMID: 20981692     DOI: 10.1002/pbc.22743

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  11 in total

1.  Neurocognitive and family functioning and quality of life among young adult survivors of childhood brain tumors.

Authors:  Matthew C Hocking; Wendy L Hobbie; Janet A Deatrick; Matthew S Lucas; Margo M Szabo; Ellen M Volpe; Lamia P Barakat
Journal:  Clin Neuropsychol       Date:  2011-07-04       Impact factor: 3.535

Review 2.  Child and adolescent self-report symptom measurement in pediatric oncology research: a systematic literature review.

Authors:  Laura C Pinheiro; Molly McFatrich; Nicole Lucas; Jennifer S Walker; Janice S Withycombe; Pamela S Hinds; Lillian Sung; Deborah Tomlinson; David R Freyer; Jennifer W Mack; Justin N Baker; Bryce B Reeve
Journal:  Qual Life Res       Date:  2017-09-06       Impact factor: 4.147

3.  Health-related quality of life of adolescent and young adult survivors of childhood brain tumors.

Authors:  Lamia P Barakat; Yimei Li; Wendy L Hobbie; Sue K Ogle; Thomas Hardie; Ellen M Volpe; Margo M Szabo; Maureen Reilly; Janet A Deatrick
Journal:  Psychooncology       Date:  2014-08-11       Impact factor: 3.894

Review 4.  Considering quality of life for children with cancer: a systematic review of patient-reported outcome measures and the development of a conceptual model.

Authors:  Samantha J Anthony; Enid Selkirk; Lillian Sung; Robert J Klaassen; David Dix; Katrin Scheinemann; Anne F Klassen
Journal:  Qual Life Res       Date:  2013-08-02       Impact factor: 4.147

5.  A prospective study of family predictors of health-related quality of life in pediatric brain tumor survivors.

Authors:  Lauren F Quast; Peter C Phillips; Yimei Li; Anne E Kazak; Lamia P Barakat; Matthew C Hocking
Journal:  Pediatr Blood Cancer       Date:  2018-01-19       Impact factor: 3.167

6.  Computerized Adaptive Testing in Pediatric Brain Tumor Clinics.

Authors:  Jin-Shei Lai; Jennifer L Beaumont; Cindy J Nowinski; David Cella; William F Hartsell; John Han-Chih Chang; Peter E Manley; Stewart Goldman
Journal:  J Pain Symptom Manage       Date:  2017-08-08       Impact factor: 3.612

7.  Promoting an ethic of engagement in pediatric palliative care research.

Authors:  Vasiliki Rahimzadeh; Gillian Bartlett; Cristina Longo; Laura Crimi; Mary Ellen Macdonald; Nada Jabado; Carolyn Ells
Journal:  BMC Palliat Care       Date:  2015-10-16       Impact factor: 3.234

8.  Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial.

Authors:  Hugo Câmara-Costa; Kim S Bull; Colin Kennedy; Andreas Wiener; Gabriele Calaminus; Anika Resch; Virginie Kieffer; Clémence Lalande; Geraldina Poggi; Katja von Hoff; Jacques Grill; François Doz; Stefan Rutkowski; Maura Massimino; Rolf-Dieter Kortmann; Birgitta Lannering; Georges Dellatolas; Mathilde Chevignard
Journal:  Neurooncol Pract       Date:  2017-02-10

9.  Psychosocial profile of pediatric brain tumor survivors with neurocognitive complaints.

Authors:  Marieke Anna de Ruiter; Antoinette Yvonne Narda Schouten-van Meeteren; Dannis Gilbert van Vuurden; Heleen Maurice-Stam; Corrie Gidding; Laura Rachel Beek; Bernd Granzen; Jaap Oosterlaan; Martha Alexandra Grootenhuis
Journal:  Qual Life Res       Date:  2015-08-20       Impact factor: 4.147

10.  Predicting trajectories of behavioral adjustment in children diagnosed with acute lymphoblastic leukemia.

Authors:  Simone M Sint Nicolaas; Peter M Hoogerbrugge; Esther M M van den Bergh; José A E Custers; Sofia Gameiro; Reinoud J B J Gemke; Chris M Verhaak
Journal:  Support Care Cancer       Date:  2016-06-14       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.